Advances in Microscopy: A Gateway to Enhanced Research, Drug Development, and Diagnostics
Monday, July 29 | 8AM PDT | 11AM EDT | 5PM CEST
Join us and our special guest speaker Prof. Nicole Endlich from the Department of Anatomy and Cell Biology at Greifswald University Medicine and CEO of NIPOKA GmbH, Germany, for this webinar on “Advances in Microscopy: A Gateway to Enhanced Research, Drug Development, and Diagnostics”.
Bruker’s Acquifer IM (Imaging Machine) is a fully automated widefield microscope ideal for high-content screening assays and phenotypic screening for small-model organisms. Its static sample holder and moving optics renders it ideal for imaging motion-sensitive samples, such as non-adherent cell cultures or embryos.
In this webinar, Prof. Nicole Endlich will give an overview of her research on kidney disease and the development of new diagnostic tools. She will speak on:
- Developing high-content screening methods based on a zebrafish larvae model for the identification of potential therapeutic agents
- Combing super resolution-based imaging techniques with multiplex staining and in situ hybridization for the advanced visualization of structure and morphology
Please download the program for details.
Meet the Guest Speaker
Prof. Dr. Nicole Endlich
CEO of NIPOKA
Greifswald University Medicine
Greifswald, Germany
CEO of NIPOKA
Greifswald University Medicine
Greifswald, Germany
Prof. Dr. Nicole Endlich studied chemistry at the University Heidelberg, where she received her doctorate in physical chemistry. She has over 20 years’ experience as a kidney researcher with a focus on podocyte-associated kidney diseases, which account for 80 % of all kidney diseases. She has also worked on the investigation of signaling pathways and the identification of therapeutic agents, mainly in the zebrafish model by developing high-content screening methods in her research unit at the University Medicine Greifswald, where she is Managing Director of the Department of Anatomy and Cell Biology. Her group has done pioneering work in kidney diagnostics using state-of-the-art super-resolution microscopy. Based on this technology, Prof. Dr. Endlich founded the startup NIPOKA GmbH in 2019, where she is CEO.
